We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

87:HKEXSwire Pacific Limited Class B Analysis

Data as of 2026-03-16 - not real-time

¥1,911.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

SPARX Group Co., Ltd. is trading at ¥1,911, comfortably above its 50‑day SMA of ¥1,876 but below the 20‑day SMA of ¥2,017, indicating a short‑term pullback within a broader bullish framework. The RSI of 44 suggests neutral momentum, while the MACD histogram remains negative, flagging modest bearish pressure despite an overall bullish trend direction. Volume is on an increasing trajectory, supporting the price resilience, yet the 30‑day volatility of 54.6% signals sizable price swings. The stock’s beta, under 0.4, points to low systematic risk, cushioning it against market turbulence.
Fundamentally, the company posts a solid PE of 12.95 against an industry average of 16.35, positioning it as undervalued. Revenue growth of 19.3% and an operating margin near 47% underscore robust earnings power. A dividend yield of 4.68% with a payout ratio of 46% suggests a sustainable income stream, while the max drawdown of roughly ‑24.8% remains within acceptable bounds for a defensive asset. Collectively, these metrics paint a picture of a financially sound, dividend‑rich stock with upside potential amid modest valuation discounts.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just above the 50‑day SMA, indicating near‑term support
  • Increasing volume reinforcing current price levels
  • MACD bearish histogram suggesting limited upside in the immediate horizon

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued PE relative to industry peers
  • Strong revenue growth and high operating margins
  • Attractive dividend yield with a comfortable payout ratio

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustainable dividend policy providing reliable cash flow
  • Low beta indicating defensive characteristics over time
  • Consistent profitability metrics (ROE ~18%) supporting long‑term stability

Key Metrics & Analysis

Financial Health

Revenue Growth19.30%
Profit Margin34.24%
P/E Ratio12.9
ROE18.31%
ROA10.48%
Debt/Equity27.36
P/B Ratio2.0
Industry P/E16.4

Technical Analysis

TrendBullish
RSI44.3
Support¥1,881.00
Resistance¥2,142.00
MA 20¥2,017.15
MA 50¥1,876.18
MA 200¥1,611.92
MACDBearish
VolumeIncreasing
Fear & Greed Index75.43

Valuation

GradeUndervalued
TypeBlend
Dividend Yield4.68%

Risk Assessment

Beta0.30
Volatility54.60%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.